Reduced BAFF-R and increased TACI expression in common variable immunodeficiency
- PMID: 24809296
- DOI: 10.1007/s10875-014-0047-y
Reduced BAFF-R and increased TACI expression in common variable immunodeficiency
Abstract
Purpose: B-cell survival and differentiation critically depend on the interaction of BAFF-R and TACI with their ligands, BAFF and APRIL. Mature B-cell defects lead to Common Variable Immunodeficiency (CVID), which is associated with elevated serum levels of BAFF and APRIL. Nevertheless, BAFF-R and TACI expression in CVID and their relationship with ligand availability remain poorly understood.
Methods and results: We found that BAFF-R expression was dramatically reduced on B cells of CVID patients, relative to controls. BAFF-R levels inversely correlated with serum BAFF concentration both in CVID and healthy subjects. We also found that recombinant BAFF stimulation reduced BAFF-R expression on B cells without decreasing transcript levels. On the other hand, CVID subjects had increased TACI expression on B cells in direct association with serum BAFF but not APRIL levels. Moreover, splenomegaly was associated with higher TACI expression, suggesting that perturbations of TACI function may underlie lymphoproliferation in CVID.
Conclusions: Our results indicate that availability of BAFF determines BAFF-R and TACI expression on B cells, and that BAFF-R expression is controlled by BAFF binding. Identification of the factors governing BAFF-R and TACI is crucial to understanding CVID pathogenesis, and B-cell biology in general, as well as to explore their potential as therapeutic targets.
Similar articles
-
Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.J Clin Immunol. 2012 Dec;32(6):1165-79. doi: 10.1007/s10875-012-9717-9. Epub 2012 Jun 15. J Clin Immunol. 2012. PMID: 22699762
-
High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.Clin Immunol. 2007 Aug;124(2):182-9. doi: 10.1016/j.clim.2007.04.012. Epub 2007 Jun 7. Clin Immunol. 2007. PMID: 17556024 Free PMC article.
-
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):520-6. doi: 10.1097/ACI.0b013e3283141200. Curr Opin Allergy Clin Immunol. 2008. PMID: 18978466 Review.
-
APRIL is overexpressed in cancer: link with tumor progression.BMC Cancer. 2009 Mar 16;9:83. doi: 10.1186/1471-2407-9-83. BMC Cancer. 2009. PMID: 19291294 Free PMC article.
-
Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.Int J Immunogenet. 2015 Aug;42(4):239-53. doi: 10.1111/iji.12217. Epub 2015 Jun 19. Int J Immunogenet. 2015. PMID: 26096648 Review.
Cited by
-
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.Dig Dis Sci. 2016 Dec;61(12):3407-3424. doi: 10.1007/s10620-016-4317-9. Epub 2016 Sep 21. Dig Dis Sci. 2016. PMID: 27655102 Review.
-
BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency.JCI Insight. 2019 Mar 7;4(5):e122728. doi: 10.1172/jci.insight.122728. eCollection 2019 Mar 7. JCI Insight. 2019. PMID: 30843876 Free PMC article.
-
Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14. Biol Blood Marrow Transplant. 2019. PMID: 30447393 Free PMC article.
-
The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.Haematologica. 2017 Jan;102(1):192-202. doi: 10.3324/haematol.2016.149112. Epub 2016 Sep 15. Haematologica. 2017. PMID: 27634199 Free PMC article.
-
Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice.Blood Adv. 2017 Dec 19;1(27):2729-2741. doi: 10.1182/bloodadvances.2017010090. eCollection 2017 Dec 26. Blood Adv. 2017. PMID: 29296925 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous